M Holdings Securities Inc. Sells 2,500 Shares of Phreesia, Inc. (NYSE:PHR)

M Holdings Securities Inc. cut its stake in shares of Phreesia, Inc. (NYSE:PHR) by 14.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,000 shares of the company’s stock after selling 2,500 shares during the quarter. M Holdings Securities Inc.’s holdings in Phreesia were worth $342,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Champlain Investment Partners LLC grew its holdings in Phreesia by 4.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after acquiring an additional 97,847 shares during the last quarter. TimesSquare Capital Management LLC grew its stake in shares of Phreesia by 2.3% in the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after purchasing an additional 19,395 shares during the last quarter. Silvercrest Asset Management Group LLC increased its holdings in Phreesia by 4.5% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 447,638 shares of the company’s stock valued at $10,712,000 after purchasing an additional 19,454 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Phreesia by 3.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 447,239 shares of the company’s stock valued at $10,193,000 after purchasing an additional 16,112 shares during the period. Finally, Bellevue Group AG raised its position in Phreesia by 5.2% during the 1st quarter. Bellevue Group AG now owns 443,341 shares of the company’s stock valued at $10,609,000 after purchasing an additional 21,768 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors.

Insider Transactions at Phreesia

In related news, General Counsel Allison C. Hoffman sold 14,110 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $26.03, for a total transaction of $367,283.30. Following the completion of the sale, the general counsel now owns 121,003 shares in the company, valued at approximately $3,149,708.09. This trade represents a 10.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP David Linetsky sold 1,716 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $39,897.00. Following the completion of the transaction, the senior vice president now directly owns 203,318 shares in the company, valued at approximately $4,727,143.50. This represents a 0.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 44,107 shares of company stock valued at $1,035,226 over the last quarter. 5.80% of the stock is currently owned by company insiders.

Phreesia Stock Up 4.6 %

Shares of Phreesia stock opened at $19.87 on Friday. The company has a market cap of $1.15 billion, a price-to-earnings ratio of -11.04 and a beta of 0.94. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The company’s 50 day moving average is $20.79 and its 200 day moving average is $21.91. Phreesia, Inc. has a twelve month low of $14.55 and a twelve month high of $29.16.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.06. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. The business had revenue of $102.12 million during the quarter, compared to the consensus estimate of $101.76 million. Research analysts anticipate that Phreesia, Inc. will post -1.23 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on PHR shares. JPMorgan Chase & Co. raised their target price on shares of Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Monday, September 9th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. DA Davidson reissued a “buy” rating and issued a $32.00 target price on shares of Phreesia in a research report on Thursday, September 5th. Truist Financial lifted their price target on Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, September 6th. Finally, Robert W. Baird upped their price target on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a research note on Friday, September 6th. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $29.42.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.